OneMain Financial (OMF) Prices 10.01M Share Secondary Offering
- Wall Street rebounds in broad rally as Omicron jitters abate
- Apple (AAPL) Tells Suppliers iPhone Demand Slowing as Holidays Near - Bloomberg
- Boeing (BA) Stock Gains as China Aviation Authority Paves Way for 737 MAX Return
- Snowflake (SNOW) Stock Surges on Strong Sales and Outlook, Analysts Bulled-up
- Oil little changed as OPEC+ sticks to regular output increase
Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.
OneMain Holdings, Inc. (NYSE: OMF) (the “Company”) announced today the pricing of its previously-announced underwritten public offering of 10,010,208 shares of the Company’s common stock by an entity managed by affiliates of Apollo Global Management, Inc. (the “selling stockholder”). The 10,010,208 shares of common stock being sold in this offering represent approximately 7.6% of the Company’s outstanding common stock as of the close of business on October 15, 2021 and represent all of the shares held by the selling stockholder in the Company. The Company is not selling any shares and will not receive any proceeds from the proposed offering. The offering is expected to close on October 28, 2021, subject to satisfaction of customary closing conditions.
In addition, the Company has agreed to purchase 1,870,000 shares of common stock that are the subject of the offering at a price per share equal to the price at which the underwriter will purchase such shares from the selling stockholder in the offering (the “Concurrent Share Buyback”). The Concurrent Share Buyback is contingent on, and expected to occur simultaneously with, the closing of the offering. The Company intends to fund the Concurrent Share Buyback from existing cash on hand. The underwriter will not receive any compensation for the shares being repurchased by the Company.
Barclays is acting as sole underwriter for the proposed offering. The underwriter may offer the shares from time to time to purchasers directly or through agents, or through brokers in brokerage transactions on the New York Stock Exchange, or to dealers in negotiated transactions or in a combination of such methods of sale, at a fixed price or prices, which may be changed, or at market prices prevailing at the time of sale, at prices related to such prevailing market prices or at negotiated prices.
The offering is being made only by means of a prospectus supplement and accompanying base prospectus. The Company has filed a registration statement (including a base prospectus) and a preliminary prospectus supplement with the U.S. Securities and Exchange Commission (“SEC”) for the offering to which this communication relates and will file a final prospectus supplement relating to the offering. Prospective investors should read the prospectus supplement and base prospectus in that registration statement and other documents the Company has filed or will file with the SEC for more complete information about the Company and the offering. You may obtain these documents for free by visiting EDGAR on the SEC’s website at www.sec.gov. Alternatively, copies of the final prospectus supplement, when available, and the accompanying base prospectus for the offering may be obtained by contacting Barclays Capital Inc., c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, by telephone (toll-free): (888) 603-5847 or by emailing: firstname.lastname@example.org.
This press release does not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of any of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. The securities being offered have not been approved or disapproved by any regulatory authority, nor has any such authority passed upon the accuracy or adequacy of the prospectus supplement or the shelf registration statement or prospectus.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Weibo (WB) Prices Global 11M Share Offering at HK $272.8/sh
- India Globalization Capital, Inc. (IGC) Phase 1 Clinical Trial Data Indicate THC-based Investigational New Drug May Reduce Symptoms of Dementia in Alzheimer’s Patients
- Cocrystal Pharma, Inc. (COCP) to Discuss Progress with COVID-19 Antiviral Programs and Clinical Strategy During Noble Capital Markets’ Channelchek Virtual Roadshow
Create E-mail Alert Related CategoriesCorporate News, Equity Offerings
Related EntitiesBarclays, Stock Buyback
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!